Grown Rogue International (GRUSF) Operating Income Growth (1y) (2019 - 2026)
Grown Rogue International (GRUSF) Operating Income Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -14.89% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -46.83% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 719.49% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -450.06% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -235.28% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -20.32% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 114.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.05% |
| Dec 31, 2025 | 2,392,300,276.00% |
| Sep 30, 2025 | 51,166,335.52% |
| Jun 30, 2025 | -935,860,537.43% |
| Mar 31, 2025 | -176.52% |
| Dec 31, 2024 | -85.93% |
| Jan 31, 2023 | 32.92% |
| Jan 31, 2022 | 149.30% |
| Oct 31, 2021 | 1,576.72% |
| Jul 31, 2021 | 202.81% |
| Apr 30, 2021 | -4.26% |
| Jan 31, 2021 | -652.70% |
| Oct 31, 2020 | 99.31% |
| Jul 31, 2020 | 20.11% |
| Apr 30, 2020 | 63.99% |
| Jan 31, 2020 | 103.83% |
| Oct 31, 2019 | -813.86% |
| Jul 31, 2019 | -118.06% |
| Apr 30, 2019 | -97.02% |
| Jan 31, 2019 | -370.35% |